Many pathways to hit in epigenomics to target cancer.
The picture is from this article:
Dai, W., Qiao, X., Fang, Y. et al. Epigenetics-targeted drugs: current paradigms and future challenges. Sig Transduct Target Ther 9, 332 (2024).
https://doi.org/10.1038/s41392-024-02039-0
Medicinal chemists have been using fluorine as a Hydrogen substitute in drug discovery for a long time. It has been used in drug discovery to the extent that nearly 25% of the drugs today including some of the block busters have fluorine in them; like Prozac, Lipitor and Pervacid. Why do chemists use it? As…
Nearly 100 cancer physicians had published a report in Blood that the prices of drugs for cancer that typically cost about $100,000 per year are unsustainable and something needs to be done to manage that for the patients. The article is worth a read and compares a UK study which typically puts as a life…
Face recognition technology has come a long way. The technology now enables the specific association of the face with a name and thus confirmed identification. The technology of recognition is very complex and requires not only significant image processing of the face to identify features of interest but also then matching the features with those…
NF1 – major optic glioama Half of them will be affected and others not. The eye is affected even though glioma’s are not life threatening. The tumor and eye will not be matched in some cases. Visual acuity – Vision develops in childhood – they do not see 20/20 till they are 6 years old….
A synthetic biology company called Huue is going forward to create dye’s from bacteria. The cool part is that they are taking machinery that is in plants and introducing them into bacteria.An advantage is that you could manipulate and then come up with new dyes. The dye Huue has started with is called Indigo and…
There have been so many multi-cancer early detection tests coming on the market and the users are generally not aware of them – each of them have a different capability and strengths. Genomeweb had done a survey of what are the tests available and how they are perceived. Look at the survey at : https://www.genomeweb.com/cancer/genomeweb-survey-enthusiasm-mced-tests-research-and-clinical-care-despite-evidence-caveats…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |